97 related articles for article (PubMed ID: 21288974)
1. The inhibitory effect of lidocaine on the release of high mobility group box 1 in lipopolysaccharide-stimulated macrophages.
Wang HL; Zhang WH; Lei WF; Zhou CQ; Ye T
Anesth Analg; 2011 Apr; 112(4):839-44. PubMed ID: 21288974
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine inhibits the secretion of high mobility group box 1 from lipopolysaccharide-activated macrophages in vitro.
Chang Y; Huang X; Liu Z; Han G; Huang L; Xiong YC; Wang Z
J Surg Res; 2013 May; 181(2):308-14. PubMed ID: 22939552
[TBL] [Abstract][Full Text] [Related]
3. Magnesium sulfate inhibits the secretion of high mobility group box 1 from lipopolysaccharide-activated RAW264.7 macrophages in vitro.
Liu Z; Zhang J; Huang X; Huang L; Li S; Wang Z
J Surg Res; 2013 Jan; 179(1):e189-95. PubMed ID: 22487382
[TBL] [Abstract][Full Text] [Related]
4. Magnesium deficiency promotes secretion of high-mobility group box 1 protein from lipopolysaccharide-activated macrophages in vitro.
Liu Z; Chang Y; Zhang J; Huang X; Jiang J; Li S; Wang Z
J Surg Res; 2013 Apr; 180(2):310-6. PubMed ID: 22608546
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein induces high-mobility group box-1 protein release through activation of p38MAPK in macrophage RAW264.7 cells.
Kawahara K; Biswas KK; Unoshima M; Ito T; Kikuchi K; Morimoto Y; Iwata M; Tancharoen S; Oyama Y; Takenouchi K; Nawa Y; Arimura N; Jie MX; Shrestha B; Miura N; Shimizu T; Mera K; Arimura S; Taniguchi N; Iwasaka H; Takao S; Hashiguchi T; Maruyama I
Cardiovasc Pathol; 2008; 17(3):129-38. PubMed ID: 18402807
[TBL] [Abstract][Full Text] [Related]
6. Penehyclidine hydrochloride inhibits the release of high-mobility group box 1 in lipopolysaccharide-activated RAW264.7 cells and cecal ligation and puncture-induced septic mice.
Yang Q; Liu X; Yao Z; Mao S; Wei Q; Chang Y
J Surg Res; 2014 Jan; 186(1):310-7. PubMed ID: 24124976
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro effects of the anticoagulant, thrombomodulin, on the inflammatory response in rodent models.
Hagiwara S; Iwasaka H; Matsumoto S; Hasegawa A; Yasuda N; Noguchi T
Shock; 2010 Mar; 33(3):282-8. PubMed ID: 19536047
[TBL] [Abstract][Full Text] [Related]
8. CKD712, (S)-1-(α-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, inhibits the lipopolysaccharide-stimulated secretion of HMGB1 by inhibiting PI3K and classical protein kinase C.
Oh YJ; Youn JH; Min HJ; Kim DH; Lee SS; Choi IH; Shin JS
Int Immunopharmacol; 2011 Sep; 11(9):1160-5. PubMed ID: 21457762
[TBL] [Abstract][Full Text] [Related]
9. Carbon monoxide from CORM-2 reduces HMGB1 release through regulation of IFN-β/JAK2/STAT-1/INOS/NO signaling but not COX-2 in TLR-activated macrophages.
Tsoyi K; Nizamutdinova IT; Jang HJ; Mun L; Kim HJ; Seo HG; Lee JH; Chang KC
Shock; 2010 Dec; 34(6):608-14. PubMed ID: 20442692
[TBL] [Abstract][Full Text] [Related]
10. Nafamostat mesilate inhibits high-mobility group box 1 by lipopolysaccharide stimulation in murine macrophage RAW 264.7.
Hagiwara S; Iwasaka H; Matumoto S; Noguchi T
Shock; 2007 Apr; 27(4):429-35. PubMed ID: 17414427
[TBL] [Abstract][Full Text] [Related]
11. PACAP inhibit the release and cytokine activity of HMGB1 and improve the survival during lethal endotoxemia.
Tang Y; Lv B; Wang H; Xiao X; Zuo X
Int Immunopharmacol; 2008 Dec; 8(12):1646-51. PubMed ID: 18713653
[TBL] [Abstract][Full Text] [Related]
12. The alarmin cytokine, high mobility group box 1, is produced by viable cardiomyocytes and mediates the lipopolysaccharide-induced myocardial dysfunction via a TLR4/phosphatidylinositol 3-kinase gamma pathway.
Xu H; Su Z; Wu J; Yang M; Penninger JM; Martin CM; Kvietys PR; Rui T
J Immunol; 2010 Feb; 184(3):1492-8. PubMed ID: 20028656
[TBL] [Abstract][Full Text] [Related]
13. [Ethyl pyruvate inhibited HMGB1 expression induced by LPS in macrophages].
Tian XX; Wu CX; Sun H; Gong JP; Liu Q; Guo H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Dec; 27(12):1304-7, 1311. PubMed ID: 22152811
[TBL] [Abstract][Full Text] [Related]
14. Gabexate mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury.
Hidaka S; Iwasaka H; Hagiwara S; Noguchi T
J Surg Res; 2011 Jan; 165(1):142-50. PubMed ID: 19766246
[TBL] [Abstract][Full Text] [Related]
15. KLF4 promotes the expression, translocation, and releas eof HMGB1 in RAW264.7 macrophages in response to LPS.
Liu J; Liu Y; Zhang H; Chen G; Wang K; Xiao X
Shock; 2008 Sep; 30(3):260-6. PubMed ID: 18197146
[TBL] [Abstract][Full Text] [Related]
16. HMGB1 is phosphorylated by classical protein kinase C and is secreted by a calcium-dependent mechanism.
Oh YJ; Youn JH; Ji Y; Lee SE; Lim KJ; Choi JE; Shin JS
J Immunol; 2009 May; 182(9):5800-9. PubMed ID: 19380828
[TBL] [Abstract][Full Text] [Related]
17. Changes in cell culture temperature alter release of inflammatory mediators in murine macrophagic RAW264.7 cells.
Hagiwara S; Iwasaka H; Matsumoto S; Noguchi T
Inflamm Res; 2007 Jul; 56(7):297-303. PubMed ID: 17659435
[TBL] [Abstract][Full Text] [Related]
18. Levobupivacaine inhibits lipopolysaccharide-induced high mobility group box 1 release in vitro and in vivo.
Ge Y; Hu S; Zhang Y; Wang W; Xu Q; Zhou L; Mao H
J Surg Res; 2014 Dec; 192(2):582-91. PubMed ID: 25017707
[TBL] [Abstract][Full Text] [Related]
19. RNA interference inhibits high mobility group box 1 by lipopolysaccharide-activated murine macrophage RAW 264.7 secretion.
Hu HC; Wang TY; Chen YC; Wang CC; Lin MC
J Surg Res; 2011 Jun; 168(2):e181-7. PubMed ID: 21470632
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil elastase inhibitor (sivelestat) reduces the levels of inflammatory mediators by inhibiting NF-kB.
Hagiwara S; Iwasaka H; Hidaka S; Hasegawa A; Noguchi T
Inflamm Res; 2009 Apr; 58(4):198-203. PubMed ID: 19169649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
